BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32250974)

  • 1. Glucose metabolism in Cushing's syndrome.
    Sharma A; Vella A
    Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):140-145. PubMed ID: 32250974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of diabetes mellitus in Cushing's syndrome.
    Pivonello R; De Leo M; Vitale P; Cozzolino A; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():77-81. PubMed ID: 20829623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing's syndrome: an in-vivo microdialysis study.
    Krsek M; Rosická M; Nedvídková J; Kvasnicková H; Hána V; Marek J; Haluzík M; Lai EW; Pacák K
    Physiol Res; 2006; 55(4):421-428. PubMed ID: 16238457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis.
    Page R; Boolell M; Kalfas A; Sawyer S; Pestell R; Ward G; Alford F
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):509-17. PubMed ID: 1769133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical investigation on the mechanism of glucose intolerance in Cushing's syndrome].
    Takeda N; Yasuda K; Horiya T; Yamada H; Imai T; Kitada M; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):631-48. PubMed ID: 3525245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression changes in subcutaneous adipose tissue due to Cushing's disease.
    Hochberg I; Harvey I; Tran QT; Stephenson EJ; Barkan AL; Saltiel AR; Chandler WF; Bridges D
    J Mol Endocrinol; 2015 Oct; 55(2):81-94. PubMed ID: 26150553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic comorbidities in Cushing's syndrome.
    Ferraù F; Korbonits M
    Eur J Endocrinol; 2015 Oct; 173(4):M133-57. PubMed ID: 26060052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and lipid metabolism abnormalities in Cushing's syndrome.
    Salehidoost R; Korbonits M
    J Neuroendocrinol; 2022 Aug; 34(8):e13143. PubMed ID: 35980242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue in cortisol excess: What Cushing's syndrome can teach us?
    Bavaresco A; Mazzeo P; Lazzara M; Barbot M
    Biochem Pharmacol; 2024 May; 223():116137. PubMed ID: 38494065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.
    Rebuffé-Scrive M; Krotkiewski M; Elfverson J; Björntorp P
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1122-8. PubMed ID: 3142910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipogenesis in adipose tissue of patients with obesity and Cushing's disease.
    Galton DJ; Wilson JP
    Clin Sci; 1972 Dec; 43(6):17P. PubMed ID: 4264997
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does central obesity reflect "Cushing's disease of the omentum"?
    Bujalska IJ; Kumar S; Stewart PM
    Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome.
    Morgan SA; Hassan-Smith ZK; Lavery GG
    Eur J Endocrinol; 2016 Aug; 175(2):R83-9. PubMed ID: 26957494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of obesity and Cushing's disease on the incorporation of glucose into lipid and esterification of palmitate by human adipose tissue.
    Wilson JP; Galton DJ
    Eur J Clin Invest; 1972 Nov; 2(6):379-83. PubMed ID: 4266190
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucose metabolism in patients with subclinical Cushing's syndrome.
    Giordano R; Guaraldi F; Berardelli R; Karamouzis I; D'Angelo V; Marinazzo E; Picu A; Ghigo E; Arvat E
    Endocrine; 2012 Jun; 41(3):415-23. PubMed ID: 22391939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased insulin binding and antilipolytic response in adipocytes from patients with Cushing's syndrome.
    Calle C; Carranza MC; Simón MA; Torres A; Mayor P
    Biosci Rep; 1987 Sep; 7(9):713-9. PubMed ID: 3322423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome in Cushing's Syndrome Patients.
    Ferraù F; Korbonits M
    Front Horm Res; 2018; 49():85-103. PubMed ID: 29894989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in the diagnosis and management of Cushing's syndrome.
    Bansal V; El Asmar N; Selman WR; Arafah BM
    Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.